申请人:ABBOTT LABORATORIES
公开号:EP0402646A1
公开(公告)日:1990-12-19
A retroviral protease inhibiting compound of the formula
or a pharmaceutical acceptable salt, prodrug or ester thereof, wherein X is a linking group;
A is
(1) substituted amino,
(2) substituted carbonyl,
(3) functionalized imino,
(4) functionalized alkyl,
(5) functionalized acyl,
(6) functionalized heterocyclic or
(7) functionalized (heterocyclic)alkyl; and B is
(1) substituted carbonyl independently defined as herein,
(2) substituted amino independently defined as herein,
(3) functionalized imino independently defined as herein,
(4) functionalized alkyl independently defined as herein,
(5) functionalized acyl independently defined as herein,
(6) functionalized heterocyclic independently defined as herein or
(7) functionalized (heterocyclic)alkyl independently defined as herein.
式中的逆转录病毒蛋白酶抑制化合物
或其药物可接受的盐、原药或酯,其中 X 是连接基团;
A 是
(1) 取代的氨基
(2) 取代的羰基
(3) 官能化亚氨基
(4) 官能化烷基
(5) 官能化酰基
(6) 官能化杂环或
(7) 官能化(杂环)烷基;且 B 是
(1) 如本文所独立定义的取代的羰基、
(2) 如本文所独立定义的取代氨基
(3) 如本文所独立定义的官能化亚氨基
(4) 如本文所独立定义的官能化烷基、
(5) 如本文所独立定义的官能化酰基、
(6) 如本文所独立定义的官能化杂环,或
(7) 本文独立定义的官能化(杂环)烷基。